FIELD: pharmaceutics.
SUBSTANCE: present invention relates to pharmaceutics, in particular to combination and composition for treating obesity, overweight and related health problems. Combination according to present invention contains pharmaceutically acceptable amount of orlistat in amount from 1 to 1.7 mg/kg and resveratrol in amount from 5 to 10 mg/kg Present invention also relates to method of treating overweight, obesity and associated health problems.
EFFECT: invention implementation allows to reduce side effects caused by components of combination separately.
11 cl, 8 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NEW NUTRATCEUTICAL COMPOSITIONS INCLUDING EPIGALLOCATECHIN GALLATE AND RASPBERRY KETONE | 2003 |
|
RU2340337C2 |
| D-TAGATOSE COMPOSITIONS AND METHODS OF PREVENTING AND TREATING ATHEROSCLEROSIS, METABOLIC SYNDROME AND SYMPTOMS THEREOF | 2009 |
|
RU2484827C2 |
| BIOLOGICALLY ACTIVE PEPTIDE AND METHODS OF USING IT | 2013 |
|
RU2537171C2 |
| OVERWEIGHT OR OBESITY REDUCTION | 2007 |
|
RU2443417C2 |
| COMPOSITION OF SUBCUTANEOUS INJECTION FOR REDUCING BODY WEIGHT AND ITS APPLICATIONS | 2017 |
|
RU2753507C2 |
| METHOD FOR COMBINED USE OF INTRANASALLY ADMINISTERED INSULIN AND ORALLY ADMINISTERED METFORMIN FOR RECOVERY OF METABOLIC AND HORMONAL PARAMETERS IN TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME | 2023 |
|
RU2824275C1 |
| METHOD OF TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS AND MEDICATION FOR TREATING OBESITY AND ACCOMPANYING METABOLIC DISORDERS | 2010 |
|
RU2552221C2 |
| THERAPEUTIC HERBAL EXTRACT HAVING ACTION ON OBESITY | 2008 |
|
RU2475256C2 |
| COMPOSITION FOR PREVENTION AND TREATMENT OF OBESITY AND ASSOCIATED METABOLIC DISORDERS | 2020 |
|
RU2763348C2 |
| MEDICATION BASED ON SUBSTANCE INFLUENCING ENDOCANNABINOID SYSTEM | 2013 |
|
RU2568896C2 |
